Skip to main content
  • “Our dual-pronged investment strategy offers the best of both worlds to our investors – access to late-stage de-risked biopharma and medical device products, as well as early-stage therapeutics, that have the potential to generate attractive venture returns.”

    Dr. Hubert Birner, Managing Partner
  • “We are building value for our investors by providing sufficient capital to get our portfolio companies to value inflection points at the next stage of development or growth where they can have several solid exit options.”

    Stefan Fischer, Managing Partner (Finance)
  • “Our portfolio companies are partners. We give them the support they need to advance their products with the goal of bringing groundbreaking products to patients.”
    Dr. Luc Marengère, Managing Partner

Transforming healthcare together

We invest in the development of exciting life science programs and the growth of current or future innovative market segment leaders.

TVM Capital Life Science was born out of venture capital firm Techno Venture Management, which was launched in 1983 and has focused exclusively on what we know best – Life Sciences – since 2012. TVM Capital Life Science has emerged as one of the leading international venture capital firms in the field.

TVM strategically refocused in 2012 to best exploit untapped industry potential. To achieve this, we adopted a dual-investment approach. This involves creating single-asset companies to bring early-stage therapeutics to clinical proof of concept, aided by a strategic partnership with global pharmaceutical company Eli Lilly and Company (Lilly). In addition, we invest in companies with commercial-stage medtech, diagnostics, and digital health and late-stage therapeutics with the potential to change standard of care.

TVM focuses on investing in assets and companies that provide a clear and attractive exit strategy from the outset, with the goal of maximizing returns in a reasonable timeframe.

However, we contribute more than just capital. TVM has a long history of providing portfolio companies with what each uniquely needs to succeed, including recruiting new management and board members, honing development, sales and marketing plans, QMS and manufacturing/supply chain logistics, regulatory strategies, finding potential partners and carrying out financing and exit strategies.

We are proud to have been instrumental in building groundbreaking companies that became industry leaders. Together with our partners, we are re-shaping modern medicine, bringing innovative therapeutics and medical technologies to patients in need.

Meet the team

Our team members have highly complementary skill sets paired with significant industry experience, ranging from former senior pharmaceutical industry executives, drug developers and deal makers to investment managers and corporate finance specialists. This multi-faceted expertise, combined with our extensive global network in research, product development and commercialization, enables us to bring a broad perspective to the table for building successful life science products and companies.

Support from a strong network of advisors

TVM has assembled an unparalleled global advisory network of industry, medical and regulatory experts who are working at the forefront of patient care and clinical research in the areas of therapeutics, medical technology and digital health.

Their in-depth knowledge and market intelligence enables the TVM team to remain current on the latest trends, evaluate the scientific rationale and potential clinical need of an asset, identify challenges in product development/manufacturing and provide expert support and advice in development, regulatory affairs, reimbursement and commercial modeling.